Drug development firm Certara lines up three March investor talks

Certara (Nasdaq: CERT) announced its management will participate in three investor conferences in early March 2026: the TD Cowen 46th Annual Health Care Conference, the Leerink Global Healthcare Conference, and the Barclays 28th Annual Global Healthcare Conference. Live webcasts of these presentations will be available on Certara’s investor relations website and will be accessible for replay for at least 90 days. The company, a global leader in model-informed drug development, aims to accelerate medicines through biosimulation software, technology, and services.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin